To access the full text documents, please follow this link: http://hdl.handle.net/2445/111111
dc.contributor.author | Narváez García, Francisco Javier |
---|---|
dc.contributor.author | Díaz-Torné, César |
dc.contributor.author | Magallares, Berta |
dc.contributor.author | Hernández, Maria Victoria |
dc.contributor.author | Reina, Delia |
dc.contributor.author | Corominas, Héctor |
dc.contributor.author | Sanmartí Sala, Raimon |
dc.contributor.author | Rodríguez de la Serna, Arturo |
dc.contributor.author | Llobet, Josep Maria |
dc.contributor.author | Nolla Solé, Joan Miquel |
dc.date | 2017-05-16T13:18:29Z |
dc.date | 2017-05-16T13:18:29Z |
dc.date | 2015-04-01 |
dc.date | 2017-05-16T13:18:29Z |
dc.identifier.citation | 1932-6203 |
dc.identifier.citation | 654759 |
dc.identifier.uri | http://hdl.handle.net/2445/111111 |
dc.format | 9 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Public Library of Science (PLoS) |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0123392 |
dc.relation | PLoS One, 2015, vol. 10, num. 4, p. e0123392 |
dc.relation | https://doi.org/10.1371/journal.pone.0123392 |
dc.rights | cc-by (c) Narváez García, Francisco Javier et al., 2015 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Anticossos monoclonals |
dc.subject | Artritis reumatoide |
dc.subject | Metotrexat |
dc.subject | Medicaments |
dc.subject | Efectes secundaris dels medicaments |
dc.subject | Interaccions dels medicaments |
dc.subject | Monoclonal antibodies |
dc.subject | Rheumatoid arthritis |
dc.subject | Methotrexate |
dc.subject | Drugs |
dc.subject | Drug side effects |
dc.subject | Drug interactions |
dc.title | Comparative effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the treatment of rheumatoid arthritis |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |